| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| U408988-1ml |
1ml |
现货  |
|
| 英文别名 | HRP 2000, RU 44675 | (11β)-11-[4-(dimethylamino)phenyl]-17-hydroxy-19-Norpregna-4,9-diene-3,20-dione |
|---|---|
| 规格或纯度 | Moligand™, 10mM in DMSO |
| 英文名称 | Ulipristal Acetate (CDB 2914) |
| 生化机理 | 醋酸优利司他（CDB-2914，HRP 2000，RU 44675）是一种选择性 SPRM，用于无保护性交或避孕失败后的紧急避孕。 |
| 储存温度 | -80℃储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 激动剂 |
| 作用机制 | 孕酮受体调节剂 |
| 产品介绍 |
Information Ulipristal acetate (CDB-2914, HRP 2000, RU 44675) is a selectiveSPRMfor emergency contraception after an unprotected intercourse or contraceptive failure. Ulipristal acetate has partial agonistic as well as antagonistic effects on the progesterone receptor. It also binds to theglucocorticoid receptor, but has no relevant affinity to the estrogen, androgen and mineralocorticoid receptors. In vivo Based on clinical trials, ulipristal acetate seems to be a reasonably tolerable and effective method of emergency contraception when used within 120 hours of intercourse. Ulipristal acetate is at least as effective as LNG when used within the first 72 hours after unprotected intercourse. However, ulipristal acetate may be more effective than LNG when used between 72 to 120 hours after unprotected intercourse, extending the window of opportunity for emergency contraception. [2][3] cell lines： Concentrations： Incubation Time： Powder Purity:≥99% |
| 分子类型 | 小分子 |
|---|---|
| Canonical SMILES | CN(C)C1=CC=C(C=C1)C2CC3(C)C(CCC3(OC(C)=O)C(C)=O)C4CCC5=CC(=O)CCC5=C24 |
| 分子量 | 475.62 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 31 mg/mL (202.42 mM); Ethanol: 31 mg/mL (202.42 mM); Water: Insoluble; |
|---|
| Concentration(Compounding value) | 9.0-11.0(mmol/L) |
|---|---|
| Record the entire process by video | Conform |
首页
400-620-6333
